Acasti’s Capre® Lowers Triglycerides 25% - An All-Natural Blockbuster In The Making?
Acasti Pharma
TSX V: APO
Shares Outstanding: 71.0 million
Fully Diluted: 80.1 million
-------------------------------
Acasti Pharma announced interim results from its phase II open label. Based on an initial sample of 23 patients, of whom 19 had baseline triglyceride levels of between 204 and 476 mg/dl, the data for an eight week treatment with a 2 gram dose showed “a statistically significant” 25% reduction in triglycerides after an eight week treatment period.
Also, there was a “an important” decrease in Low Density Lipoprotein (LDL), Very Low Density Lipoprotein (VLDL) and non-HDL lipids and increased High Density Lipoprotein (HDL). This information aligns with the company’s objective of producing “The perfect lipid trifecta”.
Here is a table (data provided by Acasti), which outlines how Acasti’s data stacks up to other cholestrol drugs.
Dr. Harlan Waksal, Executive Vice-President, Business and Scientific Affairs was quoted in the news release,
"We are pleased with the progress of our clinical efforts. Most notably, we are very satisfied with the significant impact on triglycerides, even in this hard to treat population of patients in the lower strata of hypertriglyceridemia. Achieving statistical significance with such a low number of patients and only after a short eight-week treatment period definitely encourages us to push our strategy forward towards US clinical studies and validation during the upcoming year".
In response to this morning’s news release Hugh Cleland, Fund Manager at BluMont Capital, said the following:
“This is excellent data. In addition to showing the best trig reduction BY FAR in patients with high triglycerides relative to the 3 competing fish oil drugs, it showed decreases in LDL, AND increases in HDL, something none of GSK, Amarin nor Omthera showed with their drugs in patients with high triglycerides. It appears we not only have the "best-in-class" fish oil drug, we have something special”.
“I believe we now have even more visibility on CaPre being a drug that should sell more than $1billion/year (like GSK’s Lovaza), and could very well become a serious blockbuster (multiple billions/year)”.
http://howardgroupinsightnewsletter.blogspot.ca/search/label/Acasti%20Pharma
Recent NEPT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/30/2024 04:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/12/2024 09:02:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2024 08:42:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/12/2024 08:22:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 10:15:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 04:04:07 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/16/2024 10:20:41 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 02/15/2024 10:16:35 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/02/2024 07:02:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 03:05:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/30/2023 10:26:53 PM
- Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million • PR Newswire (US) • 11/29/2023 01:30:00 PM
- Neptune Wellness Nutraceutical Brand, Biodroga, Announces Accounts Receivable Factoring Facility of Up to $8 Million • PR Newswire (Canada) • 11/29/2023 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 02:14:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:42:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2023 09:59:26 PM
- Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million • PR Newswire (Canada) • 11/20/2023 01:00:00 PM
- Neptune Wellness Announces Letter of Intent to Acquire Leading Data-Marketing and Artificial Intelligence Company, Datasys, for Total Potential Consideration of $112 Million • PR Newswire (US) • 11/20/2023 01:00:00 PM
- Neptune Reports Fiscal Second Quarter 2024 Financial Results • PR Newswire (Canada) • 11/14/2023 10:59:00 PM
- Neptune Reports Fiscal Second Quarter 2024 Financial Results • PR Newswire (US) • 11/14/2023 10:59:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:01:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/13/2023 02:57:12 PM
- Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization • PR Newswire (Canada) • 11/08/2023 02:57:00 PM
- Neptune Wellness Announces Completion of Sprout Organic's Debt Equitization • PR Newswire (US) • 11/08/2023 02:57:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/30/2023 03:16:29 PM
FEATURED Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM
North Bay Resources Announces Mt. Vernon Gold Mine Bulk Sample, Sierra County, California • NBRI • Sep 11, 2024 9:15 AM
One World Products Issues Shareholder Update Letter • OWPC • Sep 11, 2024 7:27 AM
Kona Gold Beverage Inc. Reports $1.225 Million in Revenue and $133,000 Net Profit for the Quarter • KGKG • Sep 10, 2024 1:30 PM